Source: International Congress 2019 – Bronchiectasis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Fujita (Fukuoka , Japan), T. Sasaki (Fukuoka , Japan), R. On (Fukuoka , Japan), T. Ikeda (Fukuoka , Japan), T. Matsumoto (Fukuoka , Japan). Risk factors for the decline of pulmonary function among bronchiectasis patients in Japan. 2685

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for pulmonary Mycobacterium avium-intracellulare complex disease deterioration in immunocompetent patients Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Predictor factors of mortality in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis. Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006 Chronic sinusitis may be one of the risk factors developing and deteriorating primary MAC pulmonary disease in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011 Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Episodes of Acute Respiratory Deterioration in patients with idiopathic pulmonary fibrosis in the UK – mortality and contributing factors Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019 Prevalence and risk factors of spirometric defined chronic obstructive pulmonary disease in a Norwegian community Source: Eur Respir J 2004; 24: Suppl. 48, 358s Year: 2004 Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Lung function decline in patients with bronchiectasis Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis Year: 2018 Predictors of progression and risk of unfavorable outcome of chronic obstructive pulmonary disease Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF) Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Risk factors of treatment failure of community acquired pneumonia in patients with COPD Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008